The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
A. Kuuliala
Department of Bacteriology and Immunology
Haartman Institute
University of Helsinki
Helsinki
Finland
Name/email consistency: high
- Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Kuuliala, A., Nissinen, R., Kautiainen, H., Repo, H., Leirisalo-Repo, M. Ann. Rheum. Dis. (2006)
- Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. Kuuliala, A., Leirisalo-Repo, M., Möttönen, T., Hannonen, P., Nissilä, M., Kautiainen, H., Korpela, M., Julkunen, H., Hakola, M., Repo, H. Clin. Exp. Rheumatol. (2005)
- Circulating soluble interleukin-2 receptor level predicts remission in very early reactive arthritis. Kuuliala, A., Söderlin, M., Kautiainen, H., Repo, H., Leirisalo-Repo, M. Scand. J. Rheumatol. (2005)
- Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis. Kuuliala, A., Takala, A., Siitonen, S., Leirisalo-Repo, M., Repo, H. Scand. J. Rheumatol. (2004)
- Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study. Kuuliala, A., Eberhardt, K., Takala, A., Kautiainen, H., Repo, H., Leirisalo-Repo, M. Ann. Rheum. Dis. (2002)
